Clinical Trial Update: A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies [Phase 3]

View source ↗

Summary

The entry reports a completed Phase 3 study evaluating efalizumab for adults with plaque psoriasis, including those on concomitant antipsoriatic therapies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED